Department of Ophthalmology, Queen's University. Kingston, Ontario, Canada.
Can J Ophthalmol. 2012 Apr;47(2):145-9. doi: 10.1016/j.jcjo.2012.01.007. Epub 2012 Mar 14.
To evaluate the efficacy of a combination anaesthetic plus dilating gel (ADG) on pupil dilation (PD) and corneal anaesthesia (KA) compared to traditional preoperative pharmacotherapy for cataract surgery.
Prospective, noninferiority study.
We studied 20 consenting adults who experienced unilateral cataracts and underwent routine cataract surgery, receiving the traditional preoperative pharmacologic regimen in the operated eye (control eye): diclofenac 0.1%, gentamicin 0.3%, cyclopentolate 1%, phenylephrine 2.5%, and tropicamide 1% 60 and 20 minutes prior to surgery. They then received tetracaine 0.5% and povidone-iodine 5% 10 minutes prior to surgery; and were given tetracaine 0.5%, povidone-iodine 5%, and lidocaine 2% gel 1 minute prior to surgery. Epinephrine 0.1%, 1 cc per 500 mL bag of balanced saline salt solution was administered during surgery. The nonoperated eye (study eye) received tetracaine 0.5%, povidone-iodine 5%, and 0.35 cc ADG gel (phenylephrine 10%, tropicamide 1%, diclofenac 0.1%, and lidocaine 2%) 60 and 10 minutes prior to surgery. PD and KA were measured at baseline, at 30 minutes, and at 5 minutes prior to surgery, and at 5 minutes after surgery.
There was no difference in PD (p = 0.2634) or KA (p = 0.6058) between the study eyes and the control eyes at baseline. Preoperatively, greater mydriasis was achieved in the study eye (7.95 ± 0.91 mm vs 7.17 ± 1.25 mm; p < 0.0001). There was no significant difference in preoperative KA between the study and control eyes (1.5 ± 2.2 mm vs 1.4 ± 2.1 mm; p = 0.77).
The combination ADG for preoperative preparation of cataract patients achieves at least equivalent dilation and corneal anaesthesia as the current preoperative pharmacologic regimen.
评估联合麻醉加扩瞳凝胶(ADG)在白内障手术中与传统术前药物治疗相比对瞳孔扩张(PD)和角膜麻醉(KA)的疗效。
前瞻性非劣效性研究。
我们研究了 20 名同意接受单侧白内障手术的成年人,他们接受了传统的术前药物治疗方案(对照组):手术眼(右眼)术前 60 分钟和 20 分钟给予双氯芬酸 0.1%、庆大霉素 0.3%、环戊通 1%、苯肾上腺素 2.5%和托品酰胺 1%;术前 10 分钟给予盐酸丁卡因 0.5%和聚维酮碘 5%;术前 1 分钟给予盐酸丁卡因 0.5%、聚维酮碘 5%和利多卡因 2%凝胶。手术过程中给予肾上腺素 0.1%,每 500 毫升平衡盐溶液袋中 1 毫升。非手术眼(左眼)术前 60 分钟和 10 分钟给予盐酸丁卡因 0.5%、聚维酮碘 5%和 0.35 毫升 ADG 凝胶(苯肾上腺素 10%、托品酰胺 1%、双氯芬酸 0.1%和利多卡因 2%)。PD 和 KA 在基线、30 分钟和手术前 5 分钟以及手术后 5 分钟进行测量。
基线时,研究眼和对照眼的 PD(p = 0.2634)或 KA(p = 0.6058)无差异。术前,研究眼的瞳孔散大程度更大(7.95 ± 0.91 毫米比 7.17 ± 1.25 毫米;p < 0.0001)。研究眼和对照眼的术前 KA 无显著差异(1.5 ± 2.2 毫米比 1.4 ± 2.1 毫米;p = 0.77)。
与目前的术前药物治疗方案相比,用于白内障患者术前准备的联合 ADG 可达到至少等效的散瞳和角膜麻醉效果。